Truths about the NINDS study: setting the record straight.
Mann
Jeffrey
J
Salt Lake City, UT, USA. jmannemg@earthlink.net
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011336:Probability; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000592:standards*; D015203:Reproducibility of Results; D012720:Severity of Illness Index; D020521:Stroke / Q000188:drug therapy*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator